BACKGROUND: Infection is a severe complication after primary arthroplasty of the hip (THA) or knee joint (TKA). Based on its high sensitivity, the C-reactive protein (CRP) concentration has become a valuable tool in the diagnosis of infection, although it has only moderate specificity. Because of this, it remains unclear whether a preoperative increased CRP without clinical symptoms is a risk factor for infection after primary arthroplasty. MATERIAL AND METHODS: In a retrospective analysis, we investigated individuals with infection after primary THA or TKA and matched them with patients without infection after similar operations. Matching criteria were age, gender, and present diseases. The average age of the 50 included individuals was 67.4 (range 48-81) years, with eight men and 17 women in each group. In addition to preoperative CRP, specific patient and surgery data and microbiological and histopathologic findings were obtained. RESULTS: The average preoperative CRP concentration in the infected patient group was 1.3+/-2.5 mg/dl, in contrast to 0.4+/-0.7 mg/dl in the noninfected group. A threshold of 0.5 mg/dl was appropriate for discriminating between the two groups [13/25 (52%) in the infection group vs. 3/25 (12%) in the control group, p=0.003]. Independent from the patient group, CRP concentrations were significantly increased in individuals with diabetes mellitus (1.2+/-1.5 vs. 0.7+/-2.0 mg/dl, p=0.03). CONCLUSION: An increased preoperative CRP concentration without clinical findings of infection is a risk factor for prosthetic infection after primary THA or TKA with a threshold concentration of 0.5 mg/dl. Latent local or systemic infections or aseptic inflammation with subsequent local immune suppression seem to be responsible. We recommend evaluating CRP before every THA and TKA. For values beyond 0.5 mg/dl, an exploration for infection should be done. Otherwise, the patient should be informed about the increased risk of infection.
BACKGROUND:Infection is a severe complication after primary arthroplasty of the hip (THA) or knee joint (TKA). Based on its high sensitivity, the C-reactive protein (CRP) concentration has become a valuable tool in the diagnosis of infection, although it has only moderate specificity. Because of this, it remains unclear whether a preoperative increased CRP without clinical symptoms is a risk factor for infection after primary arthroplasty. MATERIAL AND METHODS: In a retrospective analysis, we investigated individuals with infection after primary THA or TKA and matched them with patients without infection after similar operations. Matching criteria were age, gender, and present diseases. The average age of the 50 included individuals was 67.4 (range 48-81) years, with eight men and 17 women in each group. In addition to preoperative CRP, specific patient and surgery data and microbiological and histopathologic findings were obtained. RESULTS: The average preoperative CRP concentration in the infected patient group was 1.3+/-2.5 mg/dl, in contrast to 0.4+/-0.7 mg/dl in the noninfected group. A threshold of 0.5 mg/dl was appropriate for discriminating between the two groups [13/25 (52%) in the infection group vs. 3/25 (12%) in the control group, p=0.003]. Independent from the patient group, CRP concentrations were significantly increased in individuals with diabetes mellitus (1.2+/-1.5 vs. 0.7+/-2.0 mg/dl, p=0.03). CONCLUSION: An increased preoperative CRP concentration without clinical findings of infection is a risk factor for prosthetic infection after primary THA or TKA with a threshold concentration of 0.5 mg/dl. Latent local or systemic infections or aseptic inflammation with subsequent local immune suppression seem to be responsible. We recommend evaluating CRP before every THA and TKA. For values beyond 0.5 mg/dl, an exploration for infection should be done. Otherwise, the patient should be informed about the increased risk of infection.
Authors: F Dati; G Schumann; L Thomas; F Aguzzi; S Baudner; J Bienvenu; O Blaabjerg; S Blirup-Jensen; A Carlström; P H Petersen; A M Johnson; A Milford-Ward; R F Ritchie; P J Svendsen; J Whicher Journal: Eur J Clin Chem Clin Biochem Date: 1996-06
Authors: S Botha-Scheepers; I Watt; E Slagboom; A J M de Craen; I Meulenbelt; F R Rosendaal; F C Breedveld; T W J Huizinga; M Kloppenburg Journal: Ann Rheum Dis Date: 2007-11-20 Impact factor: 19.103
Authors: Philipp T Funovics; Gundula Edelhauser; Martin A Funovics; Christoph Laux; Dominik Berzaczy; Bernd Kubista; Rainer I Kotz; Martin Dominkus Journal: Int Orthop Date: 2011-01-21 Impact factor: 3.075
Authors: Falk Mittag; Carmen Ina Leichtle; Michael Schlumberger; Ulf Gunther Leichtle; Markus Wünschel Journal: Acta Ortop Bras Date: 2016 Jan-Feb Impact factor: 0.513
Authors: Kathrine Agergård Kaspersen; Khoa Manh Dinh; Lise Tornvig Erikstrup; Kristoffer Sølvsten Burgdorf; Ole Birger Pedersen; Erik Sørensen; Mikkel Steen Petersen; Henrik Hjalgrim; Klaus Rostgaard; Kaspar Rene Nielsen; Henrik Ullum; Christian Erikstrup Journal: PLoS One Date: 2016-10-04 Impact factor: 3.240
Authors: Seung-Jae Lim; Kyung-Hwa Choi; Jin Hyuck Lee; Joon Young Jung; Woosol Han; Byung Hoon Lee Journal: Biomed Res Int Date: 2018-04-24 Impact factor: 3.411